Janus Henderson Group PLC Decreases Holdings in The Beauty Health Company (NASDAQ:SKIN)

Janus Henderson Group PLC trimmed its position in shares of The Beauty Health Company (NASDAQ:SKIN - Free Report) by 7.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,361,883 shares of the company's stock after selling 847,525 shares during the period. Janus Henderson Group PLC owned 8.35% of Beauty Health worth $16,475,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Bridgeway Capital Management LLC lifted its position in shares of Beauty Health by 13.6% in the fourth quarter. Bridgeway Capital Management LLC now owns 1,211,600 shares of the company's stock valued at $1,926,000 after acquiring an additional 145,000 shares in the last quarter. BNP Paribas Financial Markets purchased a new position in Beauty Health in the 4th quarter worth approximately $129,000. Northern Trust Corp boosted its stake in Beauty Health by 6.8% in the 4th quarter. Northern Trust Corp now owns 663,752 shares of the company's stock worth $1,055,000 after purchasing an additional 42,078 shares during the period. Price T Rowe Associates Inc. MD grew its holdings in Beauty Health by 19.2% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 114,147 shares of the company's stock valued at $182,000 after buying an additional 18,400 shares in the last quarter. Finally, Mirabella Financial Services LLP purchased a new stake in Beauty Health during the 4th quarter valued at approximately $14,292,000. Hedge funds and other institutional investors own 93.26% of the company's stock.

Analyst Ratings Changes

Separately, Canaccord Genuity Group lowered their target price on shares of Beauty Health from $1.50 to $1.25 and set a "hold" rating on the stock in a report on Monday, May 5th.

Beauty Health Price Performance

Shares of SKIN stock traded down $0.02 during trading hours on Wednesday, hitting $1.68. The stock had a trading volume of 96,709 shares, compared to its average volume of 1,056,611. The Beauty Health Company has a one year low of $0.78 and a one year high of $2.76. The company has a debt-to-equity ratio of 9.23, a current ratio of 6.56 and a quick ratio of 5.57. The stock's 50-day moving average price is $1.22 and its two-hundred day moving average price is $1.45. The stock has a market capitalization of $209.79 million, a price-to-earnings ratio of -3.96 and a beta of 0.88.

Beauty Health (NASDAQ:SKIN - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The company reported ($0.08) earnings per share for the quarter, beating the consensus estimate of ($0.13) by $0.05. Beauty Health had a negative return on equity of 44.83% and a negative net margin of 8.11%. The business had revenue of $69.60 million during the quarter, compared to analysts' expectations of $63.88 million. Equities analysts forecast that The Beauty Health Company will post -0.25 EPS for the current year.

About Beauty Health

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.